ATTO: venBio Buys $6.5M in Attovia Therapeutics Stock
Attovia Therapeutics, Inc. (ATTO) has another notable name on its insider buying ledger. venBio Global Strategic Fund IV, L.P., listed as an insider of the company, purchased 382,352 shares on the open market on August 6, 2026, at a price of $17.00 per share. The transaction totaled $6,499,984.00, funded directly by the fund rather than … Read more